Conditional survival analysis of patients with resected non–small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Conditional survival analysis of patients with resected non–small cell lung cancer

Published:2023-12 Issue: Volume:16 Page:948-959
ISSN:2666-2736
Container-title:JTCVS Open
language:en
Short-container-title:JTCVS Open

Author:

Chaudhry Talib,Krishnan Vaishnavi,Donaldson Andrew E.,Palmisano Zachary M.,Basu Sanjib,Geissen Nicole M.,Karush Justin M.,Alex Gillian C.,Borgia Jeffrey A.,Liptay Michael J.,Seder Christopher W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference27 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers;Meguid;Chest,2010

3. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial;Felip;Lancet,2021

4. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer;Forde;N Engl J Med,2022

5. Osimertinib in resected EGFR-mutated non–small-cell lung cancer;Wu;N Engl J Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP